tiprankstipranks
Viskase Holdings (ENZN)
OTHER OTC:ENZN
Want to see ENZN full AI Analyst Report?

Viskase Holdings (ENZN) Price & Analysis

92 Followers

ENZN Stock Chart & Stats

$5.99
<$0.01(0.44%)
At close: 4:00 PM EST
$5.99
<$0.01(0.44%)

Viskase Holdings News

ENZN FAQ

What was Viskase Holdings’s price range in the past 12 months?
Viskase Holdings lowest stock price was $1.53 and its highest was $12.90 in the past 12 months.
    What is Viskase Holdings’s market cap?
    Viskase Holdings’s market cap is $91.40M.
      When is Viskase Holdings’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Viskase Holdings’s earnings last quarter?
      Currently, no data Available
      Is Viskase Holdings overvalued?
      According to Wall Street analysts Viskase Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Viskase Holdings pay dividends?
        Viskase Holdings pays a Semiannually dividend of $0.12 which represents an annual dividend yield of N/A. See more information on Viskase Holdings dividends here
          What is Viskase Holdings’s EPS estimate?
          Viskase Holdings’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Viskase Holdings have?
          Viskase Holdings has 14,428,869 shares outstanding.
            What happened to Viskase Holdings’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Viskase Holdings?
            Currently, no hedge funds are holding shares in ENZN
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Company Description

              Viskase Holdings

              Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
              Similar Stocks
              Company
              Price & Change
              Follow
              AIM ImmunoTech
              GT Biopharma
              PharmaCyte Biotech
              Processa Pharmaceuticals

              Ownership Overview

              93.05%6.95%
              93.05% Insiders
              ― Other Institutional Investors
              6.95% Public Companies and
              Individual Investors

              Options Prices

              Currently, No data available
              ---
              Popular Stocks